• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病的高危筛查:通过串联质谱法分析滤纸上收集的尿液中的球三糖神经酰胺(Gb)

High-Risk Screening for Fabry Disease: Analysis by Tandem Mass Spectrometry of Globotriaosylceramide (Gb ) in Urine Collected on Filter Paper.

作者信息

Auray-Blais Christiane, Lavoie Pamela, Boutin Michel, Abaoui Mona

机构信息

Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

出版信息

Curr Protoc Hum Genet. 2017 Apr 6;93:17.26.1-17.26.12. doi: 10.1002/cphg.34.

DOI:10.1002/cphg.34
PMID:28384397
Abstract

Fabry disease is a complex, panethnic lysosomal storage disorder. It is characterized by the accumulation of glycosphingolipids in tissues, organs, the vascular endothelium, and biological fluids. The reported incidence in different populations is quite variable, ranging from 1:1400 to 1:117,000. Its complexity lies in the marked genotypic and phenotypic heterogeneity. Despite the fact that it is an X-linked disease, more than 600 mutations affect both males and females. In fact, some females may be affected as severely as males. The purpose of this protocol is to focus on the high-risk screening of patients who might have Fabry disease using a simple, rapid, non-invasive high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for urinary globotriaosylceramide (Gb ) analysis. Urine filter paper samples are easily collected at home by patients and sent by regular mail. This method has been successfully used for high-risk screening of patients with ophthalmologic manifestations and in an on-going study for high-risk screening of Fabry disease in patients with chronic kidney diseases. © 2017 by John Wiley & Sons, Inc.

摘要

法布里病是一种复杂的、全种族的溶酶体贮积症。其特征是糖鞘脂在组织、器官、血管内皮和生物体液中蓄积。不同人群中报道的发病率差异很大,范围从1:1400到1:117,000。其复杂性在于显著的基因型和表型异质性。尽管它是一种X连锁疾病,但超过600种突变会影响男性和女性。事实上,一些女性可能与男性受影响程度一样严重。本方案的目的是使用一种简单、快速、非侵入性的高效液相色谱-串联质谱(HPLC-MS/MS)方法对尿中球三糖神经酰胺(Gb)进行分析,重点关注可能患有法布里病患者的高危筛查。尿液滤纸样本由患者在家中轻松采集并通过平邮寄送。该方法已成功用于对有眼科表现的患者进行高危筛查,并正在用于对慢性肾病患者进行法布里病高危筛查的研究。© 2017约翰威立国际出版公司

相似文献

1
High-Risk Screening for Fabry Disease: Analysis by Tandem Mass Spectrometry of Globotriaosylceramide (Gb ) in Urine Collected on Filter Paper.法布里病的高危筛查:通过串联质谱法分析滤纸上收集的尿液中的球三糖神经酰胺(Gb)
Curr Protoc Hum Genet. 2017 Apr 6;93:17.26.1-17.26.12. doi: 10.1002/cphg.34.
2
High-Risk Screening of Fabry Disease: Analysis of Fifteen Urinary Methylated and Non-Methylated Gb Isoforms Using Tandem Mass Spectrometry.法布里病的高危筛查:使用串联质谱法分析15种尿甲基化和非甲基化Gb异构体
Curr Protoc Hum Genet. 2016 Oct 11;91:17.24.1-17.24.11. doi: 10.1002/cphg.24.
3
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry.采用串联质谱法对法布里病患儿进行尿生物标志物研究。
Clin Chim Acta. 2015 Jan 1;438:195-204. doi: 10.1016/j.cca.2014.08.002. Epub 2014 Aug 19.
4
Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease Patients.采用 LC-MS/MS 法对法布雷病患者尿液中的乳糖基神经酰胺、半乳糖基神经酰胺和Globotriaosylceramide 进行分离和分析。
Anal Chem. 2017 Dec 19;89(24):13382-13390. doi: 10.1021/acs.analchem.7b03609. Epub 2017 Nov 27.
5
Analysis of Globotriaosylceramide (Gb) in Liquid Urine: A Straightforward Assay Using Tandem Mass Spectrometry.液相尿液中神经节苷脂Gb 的分析:一种使用串联质谱的简单方法。
Curr Protoc. 2024 Jun;4(6):e1087. doi: 10.1002/cpz1.1087.
6
Determination of globotriaosylceramide in plasma and urine by mass spectrometry.采用质谱法测定血浆和尿液中的神经节苷脂 GM3
Clin Chem Lab Med. 2010 Feb;48(2):189-98. doi: 10.1515/CCLM.2010.048.
7
Tandem mass spectrometry multiplex analysis of methylated and non-methylated urinary Gb3 isoforms in Fabry disease patients.法布里病患者尿液中甲基化和非甲基化Gb3异构体的串联质谱多重分析。
Clin Chim Acta. 2016 Jan 15;452:191-8. doi: 10.1016/j.cca.2015.11.018. Epub 2015 Nov 22.
8
High-risk screening for Fabry disease in a Canadian cohort of chronic kidney disease patients.对加拿大慢性肾脏病患者队列进行法布雷病高危筛查。
Clin Chim Acta. 2020 Feb;501:234-240. doi: 10.1016/j.cca.2019.10.045. Epub 2019 Nov 26.
9
Development of a filter paper method potentially applicable to mass and high-risk urinary screenings for Fabry disease.
J Inherit Metab Dis. 2007 Feb;30(1):106. doi: 10.1007/s10545-006-0444-3. Epub 2006 Dec 14.
10
A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients.一种基于基质辅助激光解吸电离飞行时间质谱的新型快速方法,用于测量法布里病患者尿中的球三糖神经酰胺。
J Am Soc Mass Spectrom. 2016 Apr;27(4):719-25. doi: 10.1007/s13361-015-1318-4. Epub 2016 Jan 21.

引用本文的文献

1
Quantitation of a Urinary Profile of Biomarkers in Gaucher Disease Type 1 Patients Using Tandem Mass Spectrometry.采用串联质谱法定量分析1型戈谢病患者尿液生物标志物谱
Diagnostics (Basel). 2022 Jun 8;12(6):1414. doi: 10.3390/diagnostics12061414.
2
Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy.阿帕他胺通过抑制表观遗传读蛋白,抑制接受酶替代疗法的法布雷病患者激活的先天免疫细胞中的炎症反应。
Pharmacol Res Perspect. 2022 Jun;10(3):e00949. doi: 10.1002/prp2.949.
3
Diurnal Variation of Urinary Fabry Disease Biomarkers during Enzyme Replacement Therapy Cycles.
酶替代治疗周期中尿 Fabry 病生物标志物的昼夜变化。
Int J Mol Sci. 2020 Aug 25;21(17):6114. doi: 10.3390/ijms21176114.
4
Therapeutic challenges in two adolescent male patients with Fabry disease and high antibody titres.两名患有法布里病且抗体滴度高的青少年男性患者的治疗挑战。
Mol Genet Metab Rep. 2020 Jun 24;24:100618. doi: 10.1016/j.ymgmr.2020.100618. eCollection 2020 Sep.